期刊文献+

医院重症监护室病原菌感染特点及耐药性分析 被引量:5

Analysis of Bacterial Infection and Antibiotic Resistance in ICU
下载PDF
导出
摘要 目的:了解重症监护病房(ICU)病原菌感染特点及耐药特性。方法:对我院ICU病房2004年1月至2006年9月各类感染标本中分离的578株病原菌分析整理,并对其耐药性进行分析。结果:578株病原菌感染来源前3位分别是:痰465例(占80.5%)、其次为血19例(占3.3%)和尿19例(占3.3%);感染病原菌中以革兰氏阴性杆菌为主,427株(占73.6%),其次为酵母菌109株(占18.8%)革兰氏阳性球菌44株(占7.6%),在革兰氏阴性杆菌中非发酵菌291株(占68.1%),肠杆菌科细菌136株(占31.9%),常用抗菌素中:耐药率>50%的有氨苄西林、复方新诺明;亚胺培南对肠杆菌科的细菌耐药率为0%,但对非发酵菌有较高的耐药率。结论:ICU中感染严重,存在普遍的耐药性,根据微生物药敏结果选择用药很是必要。 Objective:To investigate the characteristic of pathogens infection and drug resistance isolated from intensive care unit(ICU).Methods 578 strains of pathogens were analyzed,which were isolated from January 1,2004 to September 30,2006 in intensive care unit(ICU)of our hospital.Antimicrobial susceptibility test was done to know the drug resistance.Results The speciments predominant were sputums where 578 strains of pathogens isolated,465(accounted for 80.5%),followed by blood,19(accounted for 3.3%);urine,19(a...
出处 《华西医学》 CAS 2007年第4期825-827,共3页 West China Medical Journal
关键词 重症监护室(ICU) 感染 耐药性 Intensive care unit(ICU) Infection Drug resistance
  • 相关文献

参考文献6

二级参考文献25

  • 1魏全珍,张惠珍,钟馥霞,潘兢,钟定.超广谱β-内酰胺酶细菌感染监测及危险因素的临床研究[J].中华医院感染学杂志,2004,14(3):334-336. 被引量:24
  • 2欧阳范献,陈允凤,卜平凤,黄瑾.4年中海口地区产超广谱β-内酰胺酶阳性菌检测及其耐药性分析[J].中华医院感染学杂志,2005,15(1):85-88. 被引量:34
  • 3[1]National Committee for Clinical Laboratory Standard. Performance standards for antimicrobial susceptibility testing [ S].Twelvth informational supplement. 2002,22: 90
  • 4[2]Liu Z G, Tan C, Chen M, et al. Analysis of Enterobacter cloacae infections and antimicrobial susceptibility [J]. Chin J Nosocomial, 2000,10 (6): 472
  • 5[3]Lei D P, Xü Y C, Xie X L. Drug resistance of 109 clinical isolates of Enterobacter cloacae [ J ]. Shanghai J Med Lab Sci, 1999,14(3): 147
  • 6[4]Kang M. Resistant mechanisms of Enterobacter cloacae of βlactams [J]. FMS Microbiol, 1997,20(3) :21
  • 7[5]Zhang Y L, Li J T, Zhao M W. Studies on chacacteristics of AmpC-type beta-lactamases of Enterobactercloacae [J]. Chin J Antibiot ,2000,20(6) :428
  • 8[6]Weigel L M, Steward C D, Tenover F C. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceas [J]. AntimicrobAgents Chemother ,1998,42(10) :2661
  • 9[7]Linde H J, Notka F, Irtenkauf C, et al. Increase in MICs of ciprofloxacin in vivo in two closely related clinical isolates of Enterobacter cloacae [J ]. J Antimicrob Chemother, 2002,49(4) :625
  • 10National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial susceptibility testing [S].8th informationl supplemental standard.PA:NCCLS,1999.36.

共引文献357

同被引文献40

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部